This book examines the role of pharmacogenomics in optimizing hormonal therapies. It covers genetic factors influencing responses to treatments for conditions like breast cancer, thyroid disorders, and hormone replacement therapies. The book emphasizes personalized approaches to enhance therapeutic efficacy and minimize side effects in hormonal treatments. Targeted at endocrinologists and oncologists, it promotes precision medicine in hormone-related therapies.
Victoria Robertson applies pharmacogenomics to hormonal therapies in dermatology, personalizing treatments for skin conditions influenced by hormonal imbalances. Her research explores how genetic variations affect responses to hormonal medications used in managing acne and melasma. Victoria has authored numerous studies on optimizing hormonal therapy regimens through pharmacogenomic testing to enhance treatment outcomes and minimize side effects. She also offers guidelines for clinicians to utilize pharmacogenomic insights in hormonal therapy decisions, promoting personalized and effective dermatological care through genetic-informed hormonal treatments.